Among phase II trials, 121 (67.6%) did not reach statistical significance thresholds, while in phase III studies, 20 (76.9%) did not detect any difference between groups.
← all excerpts
Methodological Quality of Clinical Trials in Amyotrophic Lateral Sclerosis: A Systematic Review.
1
—
—